Preferred Name |
Autocatalytic phosphorylation of FGFR3 point mutants with enhanced kinase activity |
|
Synonyms |
|
|
Definitions |
has a Stoichiometric coefficient of 12 Activated point mutants in the transmembrane and kinase domains of FGFR3 have been shown to undergo constitutive autophosphorylation in a ligand-independent manner (Naski, 1996; Webster, 1996 and Donoghue, 1996; Webster, 1996; Bellus, 2000; Goriely, 2009). Some of the point mutants, including K650E and G380R, may also be able to further respond after exposure to ligand (Naski, 1996). Dimerization and activation of the FGFR3 transmembrane mutants is thought to occur via the formation of non-native hydrogen bonds that promote intermolecular interactions (Webster and Donoghue 1996), while the kinase domain mutants activate phosphorylation by mimicking conformational changes in the activation loop (Webster, 1996). Mutants with enhanced kinase activity appear to be activated to differing extents that, for the most part, correlate with the severity of the disease phenotype (Webster, 1996; Bellus, 2000; Goriely, 2009), although the results of in vitro kinase assays with immunoprecipitated proteins do not fully recapitulate the pathological consequences of the mutation (Goriely, 2009). K650E has also been shown to transform NIH 3T3 cells (Chesi, 2001).<br><br> Edited: Rothfels, K, 2012-05-16 Authored: Rothfels, K, 2012-02-09 Reviewed: Ezzat, S, 2012-05-15 |
|
ID |
http://purl.obolibrary.org/obo/HINO_0008100 |
|
comment |
has a Stoichiometric coefficient of 12 Activated point mutants in the transmembrane and kinase domains of FGFR3 have been shown to undergo constitutive autophosphorylation in a ligand-independent manner (Naski, 1996; Webster, 1996 and Donoghue, 1996; Webster, 1996; Bellus, 2000; Goriely, 2009). Some of the point mutants, including K650E and G380R, may also be able to further respond after exposure to ligand (Naski, 1996). Dimerization and activation of the FGFR3 transmembrane mutants is thought to occur via the formation of non-native hydrogen bonds that promote intermolecular interactions (Webster and Donoghue 1996), while the kinase domain mutants activate phosphorylation by mimicking conformational changes in the activation loop (Webster, 1996). Mutants with enhanced kinase activity appear to be activated to differing extents that, for the most part, correlate with the severity of the disease phenotype (Webster, 1996; Bellus, 2000; Goriely, 2009), although the results of in vitro kinase assays with immunoprecipitated proteins do not fully recapitulate the pathological consequences of the mutation (Goriely, 2009). K650E has also been shown to transform NIH 3T3 cells (Chesi, 2001). Edited: Rothfels, K, 2012-05-16 Authored: Rothfels, K, 2012-02-09 Reviewed: Ezzat, S, 2012-05-15 |
|
definition source |
Pubmed8640234 Pubmed11157491 Reactome, http://www.reactome.org Pubmed11055896 Pubmed8599935 Pubmed19855393 Pubmed8754806 |
|
has input | ||
has output | ||
label |
Autocatalytic phosphorylation of FGFR3 point mutants with enhanced kinase activity |
|
name |
Autocatalytic phosphorylation of FGFR3 somatic point mutants with enhanced kinase activity |
|
prefixIRI |
HINO:0008100 |
|
prefLabel |
Autocatalytic phosphorylation of FGFR3 point mutants with enhanced kinase activity |
|
seeAlso |
ReactomeREACT_121347 EC Number: 2.7.10 Reactome Database ID Release 432033485 |
|
subClassOf |